Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA spihapau@mdanderson.org. Division of Oncology, Tel-Aviv Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel. Division of Medical Oncology, National Cancer Centre Singapore, Singapore. Department of Medicine, Division of Medical Oncology and Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada. Medical Oncology Department, Vall D'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain. Molecular Therapeutics Research Unit (UITM), Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan. Center for Cancer Therapeutic Innovation, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Department of Medicine, Weill Cornell Medical College, New York, New York, USA. Memorial Sloan Kettering Cancer Center, New York, New York, USA. Department of Hematology/Oncology, University of Chicago, Chicago, Illinois, USA. Department of Hematology/Oncology, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA. Translational Clinical Oncology, Novartis Institutes for BioMedical Research Inc, East Hanover, New Jersey, USA. Oncology Data Science, Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, USA. Early Development Analytics-Statistics, Novartis Pharma AG, Basel, Switzerland. Oncology Therapeutic Area-Pharmacokinetic Sciences, Novartis Institutes for BioMedical Research Inc, East Hanover, New Jersey, USA. Oncology Translational Research, Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, USA.